Mike Ragno is Business Development Manager– Drug Discovery and Preclinical CRO As an executive recruiter, how do you feel the needs of the CROs differ from other areas of the Life Science industry?   In dealing with CROs almost exclusively…

In its Measuring the Return from Pharmaceutical and Innovation series, Deloitte reported on its first nine years with a focused examination of the top 12 pharmaceutical companies. Its analysis uncovered declining trends in R&D returns throughout the biopharma industry. In…

The health and biotech industries are experiencing a boom. As the economy is coming to grips with a pandemic-affected world, these companies in these sectors have continued to operate to meet increasing demands. With unemployment rates hitting all-time highs in…

Looking at recent market trends, it’s clear that certain stages of drug development can be outsourced to help reduce spending costs, while also fueling drug discovery. The CRO market is heavily concentrated in North America, and pharma and biotech companies…

The pharmaceutical industry is used to moving targets. With frequent regulatory changes, updates to patient rights, and the continuously shifting healthcare landscape, understanding how the industry is shifting requires full-time assessment.  For those looking for new roles within the industry,…

The race to find subjects that meet the various criteria for involvement in clinical trials occasionally overwhelms the more empathetic side of the enrollment equation. With large dollar amounts invested in drug development and an intrinsic need to be faster…

Blake Nevins is the Director of Recruitment at Key Corporate Services in Indianapolis. What is full life cycle recruitment? I call on and build relationships with candidates, but I also call on employers to become Key Corporate Services (KCS) clients…

Dave Kerns, co-founder of Key Corporate Services, is attending Biotech Week Boston, which is September 9-12, 2019. Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas, science, technology and partnerships to make a positive impact…

Mergers and acquisitions – M&A for short – are a common occurrence in big business. The pharmaceuticals and biotech industries are no strangers to strategic growth and contraction when money is on the line. As an employee in one of…

The pace of scientific breakthroughs continues to quicken. The rapid discovery of new medical innovations necessitates organizations in the biotech and pharmaceutical industries continuously attract the top talent in the market. But finding the right candidates who align with your…